| Literature DB >> 36053532 |
Minju Han1, So-Ryoung Lee1, Eue-Keun Choi1,2, JungMin Choi1, Jaewook Chung1, Sang-Hyeon Park1, HuiJin Lee1, Hyo-Jeong Ahn1, Soonil Kwon1, Seung-Woo Lee3, Kyung-Do Han4, Seil Oh1,2, Gregory Y H Lip1,2,5,6.
Abstract
Importance: Guidelines recommend that all risk factors for early-onset atrial fibrillation, including lifestyle factors, be proactively managed, considering the poor prognosis of the disease. Not much is known about the association of cumulative alcohol intake with the risk of atrial fibrillation in young adults aged 20 to 39 years, especially among heavy drinkers. Objective: To explore the association of alcohol consumption with the risk of incident atrial fibrillation in young adults. Design, Setting, and Participants: Using the National Health Insurance Service database, a nationwide population-based cohort study of adults aged 20 to 39 years without prior atrial fibrillation who underwent 4 serial annual health examinations between 2009 and 2012 was conducted. The cumulative alcohol consumption burden over 4 years was calculated by assigning 1 point to more than moderate drinking (≥105 g of alcohol per week) each year. Additionally, a semiquantitative cumulative burden was calculated by assigning 0, 1, 2, and 3 points to non, mild (<105 g per week), moderate (105-210 g per week), and heavy (≥210 g per week) drinking, respectively. Data were analyzed from May to June 2021. Exposure: Amount of alcohol intake in 4 years. Main Outcomes and Measures: The primary outcome was incident atrial fibrillation during the follow-up period.Entities:
Mesh:
Year: 2022 PMID: 36053532 PMCID: PMC9440398 DOI: 10.1001/jamanetworkopen.2022.29799
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Figure 1. Flowchart of the Study
Baseline Characteristics of the Study Population
| Characteristic | No. (%) | ||||||
|---|---|---|---|---|---|---|---|
| Total (N = 1 537 836) | 4-y Cumulative burden of moderate to heavy drinking | ||||||
| 0 (n = 889 382) | 1 (n = 203 374) | 2 (n = 148 087) | 3 (n = 144 023) | 4 (n = 152 970) | |||
| Age, y | |||||||
| Mean (SD) | 29.54 (4.07) | 29.44 (4.15) | 29.26 (4.09) | 29.51 (3.99) | 29.85 (3.89) | 30.23 (3.75) | <.001 |
| 20-29 | 758 589 (49.33) | 443 576 (49.87) | 106 440 (52.34) | 74 367 (50.22) | 67 863 (47.12) | 66 343 (43.37) | <.001 |
| 30-39 | 779 247 (50.67) | 445 806 (50.13) | 96 934 (47.66) | 73 720 (49.78) | 76 160 (52.88) | 86 627 (56.63) | |
| Sex | |||||||
| Male | 1 100 099 (71.54) | 529 317 (59.52) | 164 050 (80.66) | 129 024 (87.13) | 131 883 (91.57) | 145 825 (95.33) | <.001 |
| Female | 437 737 (28.46) | 360 065 (40.48) | 39 324 (19.34) | 19 063 (12.87) | 12 140 (8.43) | 7145 (4.67) | |
| Smoking | |||||||
| Never | 737 186 (47.94) | 562 281 (63.22) | 80 389 (39.53) | 42 648 (28.80) | 30 600 (21.25) | 21 268 (13.90) | <.001 |
| Former | 226 450 (14.73) | 103 265 (11.61) | 36 130 (17.77) | 28 770 (19.43) | 28 316 (19.66) | 29 969 (19.59) | |
| Current | 574 200 (37.34) | 223 836 (25.17) | 86 855 (42.71) | 76 669 (51.77) | 85 107 (59.09) | 101 733 (66.51) | |
| Underlying comorbidities | |||||||
| Hypertension | 117 935 (7.67) | 47 930 (5.39) | 16 264 (8) | 14 541 (9.82) | 17 323 (12.03) | 21 877 (14.3) | <.001 |
| Dyslipidemia | 139 895 (9.1) | 69 112 (7.77) | 19 212 (9.45) | 15 723 (10.62) | 16 650 (11.56) | 19 198 (12.55) | <.001 |
| Chronic obstructive pulmonary disease | 42 780 (2.78) | 26 436 (2.97) | 5338 (2.62) | 3823 (2.58) | 3575 (2.48) | 3608 (2.36) | <.001 |
| Sleep apnea | 2021 (0.13) | 921 (0.1) | 332 (0.16) | 258 (0.17) | 242 (0.17) | 268 (0.18) | <.001 |
| Thyroid disease | 25 048 (1.63) | 18 344 (2.06) | 2584 (1.27) | 1576 (1.06) | 1334 (0.93) | 1210 (0.79) | <.001 |
| Diabetes | 33 279 (2.16) | 15 906 (1.79) | 4500 (2.21) | 3990 (2.69) | 4125 (2.86) | 4758 (3.11) | <.001 |
| Prior myocardial infarction | 946 (0.06) | 498 (0.06) | 149 (0.07) | 133 (0.09) | 95 (0.07) | 71 (0.05) | <.001 |
| Heart failure | 1047 (0.07) | 592 (0.07) | 159 (0.08) | 90 (0.06) | 101 (0.07) | 105 (0.07) | .33 |
| Peripheral arterial disease | 11 093 (0.72) | 6633 (0.75) | 1456 (0.72) | 999 (0.67) | 980 (0.68) | 1025 (0.67) | <.001 |
| Chronic kidney disease | 5404 (0.35) | 3738 (0.42) | 624 (0.31) | 390 (0.26) | 315 (0.22) | 337 (0.22) | <.001 |
| Prior stroke | 929 (0.06) | 540 (0.06) | 129 (0.06) | 107 (0.07) | 85 (0.06) | 68 (0.04) | .036 |
| Regular exercise | 272 060 (17.69) | 150 289 (16.9) | 38 075 (18.72) | 28 428 (19.2) | 27 216 (18.9) | 28 052 (18.34) | <.001 |
| Body mass index | |||||||
| Mean (SD) | 23.62 (4.04) | 23.05 (3.66) | 23.98 (3.59) | 24.33 (3.56) | 24.61 (3.52) | 24.85 (6.34) | <.001 |
| Obesity (BMI ≥25) | 499 408 (32.47) | 237 406 (26.69) | 72 334 (35.57) | 58 434 (39.46) | 61 442 (42.66) | 69 792 (45.62) | <.001 |
| Low income | 49 467 (3.22) | 36 257 (4.08) | 4953 (2.44) | 3116 (2.1) | 2637 (1.83) | 2504 (1.64) | <.001 |
| Glomerular filtration rate, mean (SD), mL/min/1.73m2 | 102.11 (70.67) | 102.06 (65.4) | 102.33 (76.49) | 101.97 (75.24) | 102.38 (79.77) | 101.95 (78.06) | .22 |
| Blood pressure, mean (SD), mm Hg | |||||||
| Systolic | 119.08 (12.8) | 116.75 (12.43) | 120.18 (12.48) | 121.75 (12.42) | 123.23 (12.51) | 124.63 (12.55) | <.001 |
| Diastolic | 74.93 (9.22) | 73.39 (8.92) | 75.56 (9) | 76.66 (9.06) | 77.68 (9.15) | 78.75 (9.26) | <.001 |
| Glucose, mean (SD), mg/dL | 92.16 (16.33) | 90.91 (15.32) | 92.58 (16.48) | 93.63 (17.8) | 94.4 (17.61) | 95.39 (18.16) | <.001 |
| Total cholesterol, mean (SD), mg/dL | 189.62 (34.91) | 186.91 (34.2) | 190.65 (34.77) | 192.71 (36.04) | 194.46 (35.82) | 196.42 (35.51) | <.001 |
| High-density lipoprotein, mean (SD), mg/dL | 56.07 (19.12) | 56.34 (18.52) | 55.51 (18.54) | 55.38 (17.41) | 55.7 (17.9) | 56.25 (25.01) | <.001 |
| Low-density lipoprotein, mean (SD), mg/dL | 109.36 (40.59) | 109.04 (37.22) | 110.17 (44.87) | 110.22 (42.54) | 109.77 (45.13) | 108.92 (46.49) | <.001 |
| Follow-up duration, mean (SD), y | 5.55 (1.17) | 5.53 (1.18) | 5.53 (1.18) | 5.57 (1.16) | 5.6 (1.15) | 5.6 (1.15) | <.001 |
SI conversion factors: To convert glucose to millimoles per liter, multiply by 0.0555. To convert high-density lipoprotein, low-density lipoprotein, and total cholesterol to millimoles per liter, multiply by 0.0259.
Body mass index is calculated as weight in kilograms divided by height in meters squared.
The Risk of AF According to the 4-Year Alcohol Burden and 4-Year Cumulative Amount of Alcohol Consumption
| Alcohol consumption | Participants, No. | Participants with AF, No. | IR per 1000 person-years | HR (95% CI) | |
|---|---|---|---|---|---|
| Crude | Adjusted model | ||||
| Alcohol intake ≥105 g/wk (moderate to heavy drinking) at the index date | |||||
| No | 1 157 234 | 2104 | 0.33 | 1 [Reference] | 1 [Reference] |
| Yes | 380 602 | 962 | 0.45 | 1.38 (1.28-1.49) | 1.13 (1.05-1.23) |
| NA | NA | NA | <.001 | .002 | |
| The 4-y alcohol burden (1 point to each moderate to heavy drinking [>105 g/wk] during 4 consecutive years) | |||||
| 0 | 889 382 | 1512 | 0.31 | 1 [Reference] | 1 [Reference] |
| 1 | 203 374 | 445 | 0.4 | 1.29 (1.16-1.43) | 1.14 (1.03-1.27) |
| 2 | 148 087 | 313 | 0.38 | 1.24 (1.09-1.40) | 1.04 (0.91-1.17) |
| 3 | 144 023 | 361 | 0.45 | 1.45 (1.30-1.63) | 1.16 (1.03-1.31) |
| 4 | 152 970 | 435 | 0.51 | 1.65 (1.48-1.83) | 1.25 (1.12-1.40) |
| NA | NA | NA | <.001 | <.001 | |
| Amount of alcohol consumption at the index date | |||||
| 0 | 485 221 | 838 | 0.31 | 1 [Reference] | 1 [Reference] |
| 1 (<105 g/wk) | 672 013 | 1266 | 0.34 | 1.10 (1.00-1.20) | 0.97 (0.88-1.06) |
| 2 (105-210 g/wk) | 237 069 | 557 | 0.42 | 1.35 (1.21-1.50) | 1.04 (0.93-1.16) |
| 3 (≥210 g/wk) | 143 533 | 405 | 0.51 | 1.63 (1.45-1.84) | 1.22 (1.08-1.38) |
| NA | NA | NA | <.001 | <.001 | |
| The 4-y cumulative amount of alcohol consumption | |||||
| 0 | 246 284 | 424 | 0.31 | 1 [Reference] | 1 [Reference] |
| 1 | 132 566 | 204 | 0.28 | 0.90 (0.76-1.06) | 0.90 (0.76-1.07) |
| 2 | 133 208 | 225 | 0.31 | 0.99 (0.84-1.16) | 0.97 (0.82-1.14) |
| 3 | 173 593 | 294 | 0.31 | 0.99 (0.85-1.15) | 0.92 (0.80-1.07) |
| 4 | 272 954 | 509 | 0.34 | 1.10 (0.97-1.25) | 0.96 (0.84-1.09) |
| 5 | 135 620 | 305 | 0.41 | 1.32 (1.14-1.53) | 1.08 (0.93-1.26) |
| 6 | 107 017 | 235 | 0.40 | 1.28 (1.09-1.50) | 1.02 (0.86-1.20) |
| 7 | 89 303 | 195 | 0.39 | 1.27 (1.07-1.50) | 0.98 (0.82-1.16) |
| 8 | 77 356 | 191 | 0.44 | 1.42 (1.20-1.69) | 1.07 (0.90-1.28) |
| 9 | 60 686 | 163 | 0.48 | 1.55 (1.30-1.86) | 1.16 (0.96-1.40) |
| 10 | 45 606 | 109 | 0.43 | 1.39 (1.12-1.71) | 1.02 (0.83-1.27) |
| 11 | 34 096 | 106 | 0.56 | 1.80 (1.46-2.23) | 1.31 (1.05-1.63) |
| 12 | 29 547 | 106 | 0.64 | 2.08 (1.68-2.57) | 1.47 (1.18-1.83) |
| NA | NA | NA | <.001 | .002 | |
Abbreviations: AF, atrial fibrillation; IR, incidence ratio; HR, hazard ratio; NA, not applicable.
The adjusted model was adjusted for age, sex, diabetes, hypertension, dyslipidemia, chronic obstructive pulmonary disease, sleep apnea, thyroid disease, myocardial infarction, heart failure, peripheral artery disease, chronic kidney disease, prior stroke, body mass index, smoking, performing regular exercise, and low income.
Figure 2. Cumulative Incidence Curves of Atrial Fibrillation (AF) According to 4-Year Alcohol Burden
Participants with a higher cumulative burden of alcohol consumption during the 4-year period showed a higher incidence rate for atrial fibrillation than those who sustained non-to-mild drinking (burden 0).
Figure 3. The Risk of Atrial Fibrillation According to 4-Year Alcohol Burden and 4-Year Cumulative Amount of Alcohol Consumption
On the left, when participants are divided into 5 groups according to their 4-year alcohol burden (alcohol burden defined as >105 g/wk), higher burden groups show a higher incidence rate for AF than burden 0 group. On the right, when participants are divided into 13 groups according to their 4-year cumulative amount of alcohol consumption, calculated by assigning 1, 2, and 3 points for mild, moderate, and heavy drinking, respectively (mild drinking, <105 g per week; moderate, 105-210 g per week; and heavy, ≥210 g per week), groups with more than 10 points associate with higher incidence rate for AF.
aHR indicates adjusted hazard ratio; IR, incidence rate; PY, person-year.